Paul J. Bernard

787 total citations
21 papers, 634 citations indexed

About

Paul J. Bernard is a scholar working on Organic Chemistry, Pharmacology and Orthopedics and Sports Medicine. According to data from OpenAlex, Paul J. Bernard has authored 21 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 6 papers in Pharmacology and 5 papers in Orthopedics and Sports Medicine. Recurrent topics in Paul J. Bernard's work include Synthesis and biological activity (5 papers), Bone health and osteoporosis research (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Paul J. Bernard is often cited by papers focused on Synthesis and biological activity (5 papers), Bone health and osteoporosis research (5 papers) and Cholinesterase and Neurodegenerative Diseases (4 papers). Paul J. Bernard collaborates with scholars based in United States, France and Spain. Paul J. Bernard's co-authors include Norman K. Pollock, Catherine L. Davis, Haidong Zhu, Bernard Gutin, Yanbin Dong, Sudipta Misra, Barbara A. Gower, Karl Wenger, Daniel M. Scott and Thomas J. McMurry and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, International Journal of Molecular Sciences and Journal of Medicinal Chemistry.

In The Last Decade

Paul J. Bernard

19 papers receiving 617 citations

Peers

Paul J. Bernard
R. Witt United States
D. B. Cook United Kingdom
Jennifer Sprague United States
Dirk Klee Germany
R. Witt United States
Paul J. Bernard
Citations per year, relative to Paul J. Bernard Paul J. Bernard (= 1×) peers R. Witt

Countries citing papers authored by Paul J. Bernard

Since Specialization
Citations

This map shows the geographic impact of Paul J. Bernard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Bernard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Bernard more than expected).

Fields of papers citing papers by Paul J. Bernard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul J. Bernard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Bernard. The network helps show where Paul J. Bernard may publish in the future.

Co-authorship network of co-authors of Paul J. Bernard

This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Bernard. A scholar is included among the top collaborators of Paul J. Bernard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Bernard. Paul J. Bernard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Bernard, Paul J., Maciej Maj, Krzysztof Jóźwiak, et al.. (2024). Design and Synthesis of Multi-Functional Ligands through Hantzsch Reaction: Targeting Ca2+ Channels, Activating Nrf2 and Possessing Cathepsin S Inhibitory, and Antioxidant Properties. Pharmaceutics. 16(1). 121–121. 4 indexed citations
3.
Bernard, Paul J., Lhassane Ismaïli, Thierry Roisnel, et al.. (2024). Synthesis, crystal structures, DFT calculations, and oxygen radical absorbance capacity of 5-arylidene-thiazolidine-2,4‑dione derivatives. Journal of Molecular Structure. 1323. 140672–140672.
4.
Bernard, Paul J., Maciej Maj, Bernard Refouvelet, et al.. (2023). Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer’s Disease Treatment. International Journal of Molecular Sciences. 24(11). 9742–9742. 7 indexed citations
5.
Bernard, Paul J., et al.. (2023). Calcium channel blockers’ contribution to overcoming Current drug discovery challenges in Alzheimer’s disease. Expert Opinion on Drug Discovery. 19(1). 21–32. 5 indexed citations
6.
Bernard, Paul J., et al.. (2022). Benzochromenopyrimidines: Synthesis, Antiproliferative Activity against Colorectal Cancer and Physicochemical Properties. Molecules. 27(22). 7878–7878. 4 indexed citations
8.
Pierce, Jessica L., Kehong Ding, Jianrui Xu, et al.. (2019). The glucocorticoid receptor in osteoprogenitors regulates bone mass and marrow fat. Journal of Endocrinology. 243(1). 27–42. 19 indexed citations
9.
Berger, Paige K., Norman K. Pollock, Emma Laing, et al.. (2015). Zinc Supplementation Increases Procollagen Type 1 Amino-Terminal Propeptide in Premenarcheal Girls: A Randomized Controlled Trial. Journal of Nutrition. 145(12). 2699–2704. 18 indexed citations
10.
Pollock, Norman K., Vanessa Bundy, William P. Kanto, et al.. (2011). Greater Fructose Consumption Is Associated with Cardiometabolic Risk Markers and Visceral Adiposity in Adolescents3. Journal of Nutrition. 142(2). 251–257. 91 indexed citations
11.
Pollock, Norman K., Paul J. Bernard, Barbara A. Gower, et al.. (2011). Lower Uncarboxylated Osteocalcin Concentrations in Children with Prediabetes Is Associated with β-Cell Function. The Journal of Clinical Endocrinology & Metabolism. 96(7). E1092–E1099. 65 indexed citations
12.
Pollock, Norman K., Paul J. Bernard, Bernard Gutin, et al.. (2011). Adolescent Obesity, Bone Mass, and Cardiometabolic Risk Factors. The Journal of Pediatrics. 158(5). 727–734. 68 indexed citations
13.
Pollock, Norman K., Paul J. Bernard, Karl Wenger, et al.. (2010). Lower bone mass in prepubertal overweight children with prediabetes. Journal of Bone and Mineral Research. 25(12). 2760–2769. 71 indexed citations
14.
Bonnet, Nicolas, Paul J. Bernard, Hélène Beaupied, et al.. (2007). Various effects of antidepressant drugs on bone microarchitectecture, mechanical properties and bone remodeling. Toxicology and Applied Pharmacology. 221(1). 111–118. 58 indexed citations
15.
Taylor, David, Angela Bowman, Natasha S. Hamblet, et al.. (2006). Islet neogenesis associated protein transgenic mice are resistant to hyperglycemia induced by streptozotocin. Journal of Endocrinology. 190(3). 729–737. 29 indexed citations
16.
McMurry, Thomas J., Hironao Sajiki, Daniel M. Scott, et al.. (2002). The Effect of a Phosphodiester Linking Group on Albumin Binding, Blood Half-Life, and Relaxivity of Intravascular Diethylenetriaminepentaacetato Aquo Gadolinium(III) MRI Contrast Agents. Journal of Medicinal Chemistry. 45(16). 3465–3474. 53 indexed citations
17.
Amedio, John C., et al.. (1999). A Practical Manufacturing Synthesis of 1-(R)-Hydroxymethyl-Dtpa: An Important Intermediate in the Synthesis of MRI Contrast Agents. Synthetic Communications. 29(14). 2377–2391. 12 indexed citations
18.
Amedio, John C., et al.. (1998). A Practical Preparation of 4,4-Diphenylcyclohexanol: A Key Intermediate in the Synthesis of Ms-325. Synthetic Communications. 28(20). 3895–3906. 7 indexed citations
19.
Lauffer, Randall B., Robert Dolan, Hironao Sajiki, et al.. (1996). MS-325: A small-molecule vascular imaging agent for magnetic resonance imaging. Academic Radiology. 3. S356–S358. 100 indexed citations
20.
Thiéry, Michel, R. Derom, Paul J. Bernard, et al.. (1967). Pheochromocytoma in pregnancy Including observations on the physiopathology and the enzymic histochemistry of this tumor. American Journal of Obstetrics and Gynecology. 97(1). 21–29. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026